Crossmark

Impact of follow-up interval on patients with hepatocellular carcinoma after curative ablation

Crossref DOI link: https://doi.org/10.1186/s12885-018-5069-z

Published Online: 2018-11-29

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Wenwu

Zheng, Yun

Zou, Ruhai

Shen, Jingxian

He, Wei

Yang, Zhiwen

Zhang, Yuanping

Li, Binkui

Yuan, Yunfei http://orcid.org/0000-0003-2467-3683
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81372571)

Sun Yat-Sen University Clinical Research 5010 Program (2012010)

State “973 Program” of China (2014CB542005)

Fundamental Research Funds for the Central Universities (17ykzd34)
License Information

Text and Data Mining valid from 2018-11-29
More Information

Article History

Received: 7 May 2018

Accepted: 8 November 2018

First Online: 29 November 2018

Ethics approval and consent to participate

: The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki, and the Ethics Committee of Sun Yat-sen University Cancer Center approved this study and written informed consent was obtained before treatment.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.